Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for central nervous system (CNS) diseases. Findings offer evidence for the potential of these fungi to serve as novel pharmaceuticals or […]
New research from the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai reveals that patients with moderate-to-severe atopic dermatitis (eczema) who did not initially respond to […]
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.This article was originally published on MedicalXpress.com
New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials—but with less than half […]
A new study has found that phone calls, face-to-face consumer inquiries and out-of-scope questions from staff are the main sources of distraction during the dispensing process in pharmacy settings.This article was originally published on MedicalXpress.com
ADHD stimulant meds don’t increase children’s risk of psychosis, a new study says.This article was originally published on MedicalXpress.com
A drug to treat migraine, ubrogepant, is also found to reduce common non-headache symptoms that occur in the hours preceding a migraine headache, according to the results of a large phase three clinical trial published […]
People with low wealth and income have up to 85% higher risk of receiving risky medication compared to the most affluent Danes. This is shown by a comprehensive national study led by researchers from Aarhus […]
For patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations and a blood eosinophil count of at least 300 cells/µL, mepolizumab leads to a lower annualized rate of moderate or severe exacerbations, […]
A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca